Despite the importance of Aβ aggregation in Alzheimer's disease etiology, our understanding of the sequence determinants of aggregation is sparse and largely derived from in vitro studies. For example, in vitro proline and alanine scanning mutagenesis of Aβ 40 proposed core regions important for aggregation. However, we lack even this limited mutagenesis data for the more disease-relevant Aβ 42 . Thus, to better understand the molecular determinants of Aβ 42 aggregation in a cell-based system, we combined a yeast DHFR aggregation assay with deep mutational scanning.We measured the effect of 791 of the 798 possible single amino acid substitutions on the aggregation propensity of Aβ 42 . We found that ~75% of substitutions, largely to hydrophobic residues, maintained or increased aggregation. We identified 11 positions at which substitutions, particularly to hydrophilic and charged amino acids, disrupted Aβ aggregation. These critical positions were similar but not identical to critical positions identified in previous Aβ mutagenesis studies. Finally, we analyzed our large-scale mutagenesis data in the context of different Aβ aggregate structural models, finding that the mutagenesis data agreed best with models derived from fibrils seeded using brainderived Aβ aggregates.